References
Haley K (2017) Congenital hemolytic anemia. Med Clin N Am 101:361–374
Bass GF, Tuscano ET, Tuscano JM (2014) Diagnosis and classification of autoimmune hemolytic anemia. Autoimmun Rev 13:560–564
Berentsen S (2016) Cold agglutinin disease. In: Hematology/the education program of the american society of hematology American society of hematology education program 2016, pp 226–231
Go RS, Winters JL, Kay NE (2017) How I treat autoimmune hemolytic anemia. Blood 129:2971–2979
Lecouffe-Desprets M, Neel A, Graveleau J, Leux C, Perrin F, Visomblain B, Artifoni M, Masseau A, Connault J, Pottier P, Agard C, Hamidou M (2015) Venous thromboembolism related to warm autoimmune hemolytic anemia: a case-control study. Autoimmun Rev 14:1023–1028
Allgood JW, Chaplin H Jr (1967) Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med 43:254–273
Hill A, Kelly RJ, Hillmen P (2013) Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 121:4985–4996 (quiz 5105)
Zini G, d’Onofrio G, Briggs C, Erber W, Jou JM, Lee SH, McFadden S, Vives-Corrons JL, Yutaka N, Lesesve JF (2012) ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. Int J Lab Hematol 34:107–116
Marsh GW, Lewis SM (1969) Cardiac haemolytic anaemia. Semin Hematol 6:133–149
Coombs RR, Mourant AE, Race RR (1945) A new test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol 26:255–266
Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, Holcomb JB, Illoh O, Kaplan LJ, Katz LM, Rao SV, Roback JD, Shander A, Tobian AA, Weinstein R, Swinton McLaughlin LG, Djulbegovic B (2012) Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med 157:49–58
Petz LD (2004) A physician’s guide to transfusion in autoimmune haemolytic anaemia. Br J Haematol 124:712–716
George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654–666
Wouters D, Zeerleder S (2015) Complement inhibitors to treat IgM-mediated autoimmune hemolysis. Haematologica 100:1388–1395
Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, Roth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355:1233–1243
Acknowledgements
The authors thank Dr. Lionel W. Galicier for helpful comments and Michaël A. Lopez for careful reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Boutboul, D., Touzot, F. & Szalat, R. Understanding therapeutic emergencies in acute hemolysis. Intensive Care Med 44, 482–485 (2018). https://doi.org/10.1007/s00134-017-4918-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-017-4918-6